T1	PROC 44 94	Estudio de extensión de la eficacia y la seguridad
T2	CHEM 98 104	LTP001
T3	LIVB 108 121	participantes
T4	DISO 126 156	hipertensión arterial pulmonar
#1	AnnotatorNotes T4	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T5	PROC 177 205	Estudio de extensión abierto
T6	PROC 219 274	investigan la eficacia, la seguridad y la tolerabilidad
T7	CHEM 278 284	LTP001
T8	LIVB 288 301	participantes
T9	DISO 306 336	hipertensión arterial pulmonar
#2	AnnotatorNotes T9	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T10	DISO 359 363	Enf.
#3	AnnotatorNotes T10	C0012634; Disease; Disease or Syndrome | C0221423; Illness (finding); Sign or Symptom
T11	DISO 377 382	dañan
T12	ANAT 387 403	vasos sanguíneos
#4	AnnotatorNotes T12	C0005847; Blood Vessel; Body Part, Organ, or Organ Component | C1283786; Entire blood vessel; Body Part, Organ, or Organ Component
T13	ANAT 405 413	arterias
#5	AnnotatorNotes T13	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T14	ANAT 422 430	pulmones
#6	AnnotatorNotes T14	C0024109; Lung; Body Part, Organ, or Organ Component | C1278908; Entire lung; Body Part, Organ, or Organ Component
T15	PHYS 446 461	flujo sanguíneo
#7	AnnotatorNotes T15	C0232338; Blood flow; Physiologic Function
T16	PHYS 467 501	presión en las arterias pulmonares
T17	DISO 538 560	insuficiencia cardiaca
#8	AnnotatorNotes T17	C0018801; Heart failure; Disease or Syndrome
T18	DISO 585 615	Hipertensión arterial pulmonar
#9	AnnotatorNotes T18	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T20	PROC 729 739	evaluación
#10	AnnotatorNotes T20	C1261322; Evaluation procedure; Health Care Activity
T21	LIVB 744 757	Participantes
T22	Date 762 773	actualmente
T23	DISO 820 823	HAP
#11	AnnotatorNotes T23	C2973725; Pulmonary arterial hypertension; Disease or Syndrome
T25	PROC 947 958	tratamiento
#12	AnnotatorNotes T25	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T26	Neg_cue 981 984	sin
T31	PROC 1140 1151	tratamiento
#13	AnnotatorNotes T31	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T33	LIVB 1199 1212	Participantes
T34	Date 1217 1228	actualmente
T35	Neg_cue 1229 1231	no
T37	DISO 1242 1248	signos
#14	AnnotatorNotes T37	C0311392; Physical findings; Finding
T38	Neg_cue 1252 1254	no
T39	Negated 1261 1286	respondido al tratamiento
T40	PROC 1275 1286	tratamiento
#15	AnnotatorNotes T40	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T41	LIVB 1307 1319	investigador
#16	AnnotatorNotes T41	C0035173; Research Personnel; Professional or Occupational Group
T42	PROC 1333 1344	tratamiento
#17	AnnotatorNotes T42	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T43	LIVB 1358 1371	Participantes
T44	LIVB 1392 1404	investigador
#18	AnnotatorNotes T44	C0035173; Research Personnel; Professional or Occupational Group
T45	Spec_cue 1406 1422	se beneficiarían
T46	Speculated 1427 1438	tratamiento
#19	AnnotatorNotes T46	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T47	CHEM 1443 1449	LTP001
T48	Spec_cue 1451 1457	Pueden
T51	PROC 1514 1523	protocolo
#20	AnnotatorNotes T51	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T52	DISO 1569 1586	hipersensibilidad
#21	AnnotatorNotes T52	C0020517; Hypersensitivity; Pathologic Function | C0429891; Hypersensitivity finding; Finding | C0585186; Cutaneous hypersensitivity; Disease or Syndrome
T53	PROC 1590 1601	tratamiento
#22	AnnotatorNotes T53	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T54	PROC 1618 1628	Trasplante
#23	AnnotatorNotes T54	C0040732; Transplantation; Therapeutic or Preventive Procedure
T55	PROC 1631 1656	cirugía de corazón/pulmón
T58	Neg_cue 1711 1716	salvo
T59	DISO 1720 1726	disnea
#25	AnnotatorNotes T59	C0013404; Dyspnea; Sign or Symptom
T60	Negated 1720 1726	disnea
T62	PROC 1899 1903	6MWT
T63	DISO 1913 1928	angina de pecho
#26	AnnotatorNotes T63	C0002962; Angina Pectoris; Sign or Symptom
T65	DISO 1944 1972	trastorno musculoesquelético
#28	AnnotatorNotes T65	C0026857; Musculoskeletal Diseases; Disease or Syndrome
T66	DEVI 1988 2009	dispositivos de ayuda
#29	AnnotatorNotes T66	C0036605; Self-Help Devices; Medical Device
T69	CHEM 2059 2066	fármaco
#30	AnnotatorNotes T69	C0013227; Pharmaceutical Preparations; Pharmacologic Substance
T70	DISO 2112 2121	toxicidad
#31	AnnotatorNotes T70	C0600688; Toxic effect; Injury or Poisoning
T71	DISO 2124 2151	progresión de la enfermedad
#32	AnnotatorNotes T71	C0242656; Disease Progression; Pathologic Function
T74	PROC 2216 2230	consentimiento
T75	Negated 2216 2230	consentimiento
T76	Spec_cue 2256 2262	Pueden
T79	PROC 2319 2328	protocolo
#33	AnnotatorNotes T79	C0008971; Clinical Protocols; Therapeutic or Preventive Procedure
T80	PROC 877 915	procedimientos de eficacia y seguridad
T27	Negated 1242 1248	signos
T36	PROC 1427 1438	tratamiento
T83	Speculated 1468 1496	otros criterios de inclusión
T85	Speculated 2273 2301	otros criterios de exclusión
T67	Neg_cue 2203 2211	retirada
T32	PROC 1105 1124	visitas programadas
T73	Negated 1008 1059	criterios de discontinuación del estudio principal.
#34	AnnotatorNotes T11	Tissue damage (C0010957)
T28	DISO 1684 1709	Deterioro agudo o crónico
#24	AnnotatorNotes T28	failure acute C0231176 / chronic failure C0231178 ( hallazgo relacionado con el estado clínico general)
T19	PROC 2028 2043	Discontinuación
#35	AnnotatorNotes T19	Drug administration interrupted C4552475
T29	DISO 1805 1841	interferencia en la actividad física
#36	AnnotatorNotes T29	physical activity tolerance recently decreased C2080696 
T49	PROC 648 684	consentimiento informado por escrito
